Table 1.

Participants’ clinical characteristics

Characteristic	Description
n	10
Age (years) mean, median, range	55, 57, 52–62
Sex, male, female	6, 4
Body mass index in kg m−2, mean, median, range	27.24, 27.75, 22.4–31
Diagnosis	Three patients with myelodysplastic syndrome; two patients with acute myeloid leukemia; four patients with B acute lymphoblastic lymphoma; one patient with follicular lymphoma
Donor	HLA MRD T cell replete allogeneic HCT, 100%
Myeloablative conditioning	FluBu4, 90%; CyTBI, 10%
GVHD prophylaxis	Tacrolimus and methotrexate, 100%

FluBu4, fludarabine and busulfan myeloablative conditioning; CyTBI, cyclophosphamide and total body irradiation myeloablative conditioning.